Quan Tian

发表

Platinum(IV) prodrugs entrapped within multiwalled carbon nanotubes: Selective release by chemical reduction and hydrophobicity reversal

G. Pastorin, Jian Li, S. Yap, 2012 .

Clinical Pharmacology of Cyclophosphamide and Ifosfamide

Shufeng Zhou, Quan Tian, Jing Zhang, 2006 .

Insights into oxazaphosphorine resistance and possible approaches to its circumvention.

Shufeng Zhou, S. Chan, W. Duan, 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Biomimetic hydrogels for chondrogenic differentiation of human mesenchymal stem cells to neocartilage.

Yi Yan Yang, J. Hedrick, Quan Tian, 2010, Biomaterials.

Topotecan is a substrate for multidrug resistance associated protein 4.

M. Huang, Qiang Yu, Shufeng Zhou, 2006, Current drug metabolism.

Reversal of resistance to oxazaphosphorines.

Shufeng Zhou, Quan Tian, Yi-Zhun Zhu, 2006, Current cancer drug targets.

Metabolism and Transport of Oxazaphosphorines and the Clinical Implications

Shufeng Zhou, W. Duan, Quan Tian, 2005, Drug metabolism reviews.

Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation.

M. I. Setyawati, D. Leong, Chee Fei Chin, 2012, Journal of medicinal chemistry.

Human Multidrug Resistance Associated Protein 4 Confers Resistance to Camptothecins

Shufeng Zhou, S. Chan, E. Chan, 2005, Pharmaceutical Research.

Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells

Quan Tian, P. L. Ee, Z. Ong, 2010, Investigational New Drugs.

Multidrug resistance proteins (MRPs) and implication in drug development

Shufeng Zhou, E. Chan, W. Duan, 2005 .

Injectable Biodegradable Poly(ethylene glycol)/RGD Peptide Hybrid Hydrogels for in vitro Chondrogenesis of Human Mesenchymal Stem Cells.

Yi Yan Yang, J. Hedrick, J. Hui, 2010, Macromolecular rapid communications.